Comment on CMS-2026-1255-0001
Highmark Inc.SupportBusiness
Summary: Highmark Health, a large health insurance organization, supports the proposed rule's direction toward interoperability and electronic prior authorization for drugs. However, they urge CMS to provide clearer version governance for FHIR standards, support a dual-standard transition (FHIR and X12), and provide phased timelines to ensure provider readiness and minimize operational disruption.
See attached file(s)